FDA Wants More Info on New Pen Delivery for Amylin’s Bydureon

FDA Wants More Info on New Pen Delivery for Amylin’s Bydureon

Amylin said it will comply with the FDA’s request for “incremental device-related data” and hopes to have the pen-delivery formulation of Bydureon on the market by 2013.